Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines

Antiplatelet therapy, mainly consisting of aspirin and P2Y(12) receptor antagonists, is the cornerstone of the pharmacological treatment and prevention of atherothrombotic diseases. Its use, especially in secondary cardiovascular prevention, has significantly improved patient clinical outcomes in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jourdi, Georges, Marquis-Gravel, Guillaume, Martin, Anne-Céline, Lordkipanidzé, Marie, Godier, Anne, Gaussem, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092185/
https://www.ncbi.nlm.nih.gov/pubmed/35571090
http://dx.doi.org/10.3389/fphar.2022.878416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092185/
https://www.ncbi.nlm.nih.gov/pubmed/35571090
http://dx.doi.org/10.3389/fphar.2022.878416

Ejemplares similares